VHPB Centre for Evaluation of Vaccination (CEV) |
Executive Secretary Administrative and Scientific Secretariat |
privacy statement
|
Geneva, Switzerland, March 13-14, 2003
Thursday, March 13, 2003
Chair: Johannes Hallauer and Daniel Lavanchy
09.00 - 09.30
Chair: Johannes Hallauer and Daniel Lavanchy
09.30 - 10.05
Multiple sclerosis: state of the art
Philippe Duclos (Geneva, Switzerland)
10.05 - 10.40
Thiomersal-related changes in vaccination recommendations and hepatitis B vaccine coverage among United States children 350 Kb (.ppt)
Hal Margolis (Atlanta, USA)
10.40 - 11.00
Coffee break
11.00 - 11.35
Aluminium-containing vaccines and macrophagal myofasciitis (MMF): an update
Claire-Anne Siegrist (Geneva, Switzerland)
11.35 - 12.00
Infant hepatitis B vaccination and childhood leukaemia 87 Kb (.ppt)
Hal Margolis (Atlanta, USA)
12.00 - 12.35
Vaccination and autoimmune diseases: what is the risk?
Paul-Henri Lambert (Geneva, Switzerland)
12.35 - 14.00
Lunch
Chair: Peter Grob and Wolfgang Jilg
14.00 - 14.25
Impact of safety issues in France 87 Kb (.ppt)
Nicole Guérin (Antony, France)
14.25 - 14.50
Impact of safety issues in Germany 644 Kb (.ppt)
Johannes Hallauer (Berlin, Germany)
14.50 - 15.10
Coffee break
15.10 - 15.35
Impact of safety issues in Scotland 1,386 Kb (.ppt)
Claire Bramley (Glasgow, United Kingdom)
15.35 - 16.00
New communication issues around immunisation 1,090 Kb (.ppt)
Heidi Larson (New York, USA)
16.00
Close of the day and summary by the chairs
Conference dinner
Friday, March 14, 2003
Chair: Nedret Emiroglu and André Meheus
09.00 - 09.25
Impact of safety issues in Israel 96 Kb (.ppt)
Daniel Shouval (Jerusalem, Israel)
09.25 - 09.55
International impact of vaccine safety concerns 33 Kb (.ppt)
Mark Kane (Seattle, USA)
09.55 - 10.25
Impact of litigation issues on hepatitis B vaccination 2,513 Kb (.pdf)
Robert Pless (Ottawa, Canada)
10.25 - 10.40
Coffee break
Chair: Mark Kane and Daniel Shouval
10.40 - 11.10
The Global Advisory Committee on Vaccine Safety (GACVS) and its communication strategy 214 Kb (.ppt)
Philippe Duclos (Geneva, Switzerland)
11.10 - 11.40
The role of the industry 61Kb (.ppt)
Luc Hessel (Lyon, France), Hugues Bogaerts (Rixensart, Belgium)
11.40 - 12.10
The Brighton Collaboration: comparability of vaccine safety data 419 Kb (.ppt)
Jan Bonhöffer (Basel, Switzerland)
12.10 - 12.30
The Immunization Action Coalition (IAC) 2,409 Kb (.ppt)
Deborah Wexler (Saint Paul, USA)
12.30 - 13.00
Countering the anti-vaccination movement and vaccination scares - Working with the media 4,286 Kb (.ppt)
Robert Aston (Horwich, United Kingdom)
13.00 - 14.30
Lunch
Chair: Selim Badur and Hal Margolis
14.30 - 16.00
Presentation of the VHPB meeting conclusions, including discussion
Guido François (Antwerpen, Belgium)
16.00
Close of the meeting